Unknown

Dataset Information

0

Agonistic CD40 Antibodies in Cancer Treatment.


ABSTRACT: CD40 is expressed on a variety of antigen-presenting cells. Stimulation of CD40 results in inflammation by upregulation of other costimulatory molecules, increased antigen presentation, maturation (licensing) of dendritic cells, and activation of CD8+ T cells. Here we analyzed gene expression data from The Cancer Genome Atlas in melanoma, renal cell carcinoma, and pancreatic adenocarcinoma and found correlations between CD40 and several genes involved in antigen presentation and T cell function, supporting further exploration of CD40 agonists to treat cancer. Agonist CD40 antibodies have induced anti-tumor effects in several tumor models and the effect has been more pronounced when used in combination with other treatments (immune checkpoint inhibition, chemotherapy, and colony-stimulating factor 1 receptor inhibition). The reduction in tumor growth and ability to reprogram the tumor microenvironment in preclinical models lays the foundation for clinical development of agonistic CD40 antibodies (APX005M, ChiLob7/4, ADC-1013, SEA-CD40, selicrelumab, and CDX-1140) that are currently being evaluated in early phase clinical trials. In this article, we focus on CD40 expression and immunity in cancer, agonistic human CD40 antibodies, and their pre-clinical and clinical development. With the broad pro-inflammatory effects of CD40 and its ligand on dendritic cells and macrophages, and downstream B and T cell activation, agonists of this pathway may enhance the anti-tumor activity of other systemic therapies.

SUBMITTER: Djureinovic D 

PROVIDER: S-EPMC8000216 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3883444 | biostudies-literature
| S-EPMC7471753 | biostudies-literature
| S-EPMC4975533 | biostudies-literature
| S-EPMC3164589 | biostudies-literature
| S-EPMC7062441 | biostudies-literature
2023-10-23 | GSE217407 | GEO
| S-EPMC3622184 | biostudies-literature
| S-EPMC8490940 | biostudies-literature
| S-EPMC4420683 | biostudies-literature
| S-EPMC8632329 | biostudies-literature